Congratulations to the recipients of the 2022 EndoMarch Hero of the Year Award: Dr. Stacey Missmer (USA) and Dr. Krina Zondervan (International)! Both recipients will be recognized during the Virtual Worldwide EndoMarch on March 26th, 2022.
Stacey Missmer is a Global Impact Initiative endowed Professor in Obstetrics, Gynecology, and Reproductive Biology at Michigan State University, Adjunct Professor in Epidemiology at Harvard Chan School of Public Health, and Lecturer in Pediatrics at Harvard Medical School. She is Co-founder and Scientific Director of the Boston Center for Endometriosis where she designed and leads the Adolescence to Adulthood cohort study. She is a founding Principal Investigator for the World Endometriosis Research Foundation EPHect initiative that enabled large-scale collaborative endometriosis research across the globe. She is Past Chair of the American Society for Reproductive Medicine Endometriosis Special Interest Group and President-Elect of the World Endometriosis Society. Author of more than 300 scientific publications, she is a trail blazing scientist with a lifecourse approach to discovering causes and consequences of endometriosis with current focus on establishing subtypes that will improve diagnosis and treatment selection.
Krina Zondervan is Professor of Reproductive & Genomic Epidemiology at Oxford University and Head of the Nuffield Department of Women’s and Reproductive Health. She is Co-Director of the Oxford Endometriosis CaRe Centre, integrating evidence-based clinical care with a programme of basic, clinical and translational research into endometriosis and related women’s health conditions. Trained in biomedical sciences, classical epidemiology and genetic/molecular epidemiology, her research focused on understanding the causes of common women’s health conditions through genomic and epidemiological approaches, in order to improve diagnostic and treatment options. She leads a number of global collaborative research initiatives including large-scale studies that have identified genetic variants involved in the development of endometriosis and uterine fibroids; the Global Study of Women’s Health and the World Endometriosis Research Foundation EPHect initiative. She is one of the most highly cited authors in reproductive sciences, and in 2013 was recognised as Outstanding Female Scientist (AcademiaNet, Wellcome Trust nomination).
Comments are closed.